Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lexicon Pharmaceuticals Refocuses Resources On Targeted Promotion Of INPEFA In Heart Failure And Prepares For Potential Launch Of ZYNQUISTA; Expected To Reduce 2025 Operating Costs By $40M While Fully Funding Key R&D Programs; Reduction Of Headcount By ~50%

Author: Benzinga Newsdesk | August 13, 2024 08:39am

Posted In: LXRX